SRE
66
3
GIS
28
2
FRT
45
6
ABT
62
5
MAS
56
5
AVB
64
4
EMN
56
7
OMC
61
6
JPM
67
4
LRCX
45
6
EQIX
62
2
MCO
75
2
VTR
54
5
LEN
52
2
CINF
51
4
XRX
41
6
MLM
51
3
AMG
52
2
AON
52
2
MDT
62
3
SRE
66
3
GIS
28
2
FRT
45
6
ABT
62
5
MAS
56
5
AVB
64
4
EMN
56
7
OMC
61
6
JPM
67
4
LRCX
45
6
EQIX
62
2
MCO
75
2
VTR
54
5
LEN
52
2
CINF
51
4
XRX
41
6
MLM
51
3
AMG
52
2
AON
52
2
MDT
62
3
Financhill
Back

LifeStance Health Group 10K Form

Sell
45

LFST
LifeStance Health Group

Last Price:
7.30
Seasonality Move:
-4.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFST News And Ratings

See the #1 stock for the next 7 days that we like better than LFST

LFST Financial Statistics

Sales & Book Value

Annual Sales: $1.06B
Cash Flow: $17.67M
Price / Cash Flow: 78.67
Annual Sales: $3.76
Price / Book: 1.95

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-95.29M
Gross Margin: $302.1M
Return on Equity: -6.64%
Return on Assets: -4.49%

LifeStance Health Group Earnings Forecast

Key LifeStance Health Group Financial Ratios

  • The Gross Profit Margin over the past 4 years for LFST is 28.62%.
  • The Selling, General & Administrative Expenses for LFST have been equal to 38.91% of Gross Profit Margin.
  • The Interest Expense is -11.39% of Operating Income.
  • The Net Earning history of LFST is -17.64% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

LifeStance Health Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: LFST
Website: lifestance.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 1.32
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 237.88

LFST Technical Analysis vs Fundamental Analysis

Sell
45
LifeStance Health Group (LFST) is a Sell

Is LifeStance Health Group a Buy or a Sell?